Open access · OA
via Europe PMC
Senescent Mesenchymal Stromal Cells Drive Stem Cell Aging Through Dysregulated Chemokine Synthesis.
Aging cell · 2026
Epigenetic alterations
Cellular senescence
Stem-cell exhaustion
Altered intercellular communication
Chronic inflammation
Senolytics
Abstract
Aging is accompanied by a progressive decline in tissue regenerative capacity, driven by intrinsic stem cell dysfunction and age-associated deterioration of the surrounding stem cell niche. Mesenchymal stromal cells (MSCs) are ubiquitous components of stem cell niches, where they integrate structural, metabolic, inflammatory, and paracrine cues to regulate stem cell quiescence, activation, and differentiation. With age, MSCs undergo functional decline and senescence(definition), altering their secretory and signaling profiles. Across tissues, MSC senescence emerges as an intermediate amplifier of aging: molecular, metabolic, epigenetic, and inflammatory stressors promote the senescent state, which converts these upstream insults into chemokine imbalance, chronic inflammation, and progressive loss of stem cell support. Here, we synthesize classical and emerging literature to examine how age-associated changes in MSC chemokine synthesis contribute to stem cell aging, and we propose a synthesis-based model in which MSCs translate age-associated stressors into altered chemokine repertoires that disrupt stem cell-supportive signaling. We also discuss therapeutic strategies, including chemokine-directed therapies, senolytics(definition), and MSC rejuvenation, that may restore regenerative capacity by normalizing MSC-derived signals. Together, the evidence identifies dysregulated chemokine synthesis as a conserved mechanism linking tissue-resident MSC aging to declining regenerative capacity.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1111/acel.70780
- Canonical
- link ↗
- Fetched
- 2026-10-31 MST
Cite this
APA
SN, S., & LR., B. (2026). Senescent Mesenchymal Stromal Cells Drive Stem Cell Aging Through Dysregulated Chemokine Synthesis. <em>Aging cell</em>. https://doi.org/10.1111/acel.70780
Vancouver
SN S, LR. B. Senescent Mesenchymal Stromal Cells Drive Stem Cell Aging Through Dysregulated Chemokine Synthesis. Aging cell. 2026. doi:10.1111/acel.70780.
BibTeX
@article{stein2026Senesc,
title = {Senescent Mesenchymal Stromal Cells Drive Stem Cell Aging Through Dysregulated Chemokine Synthesis.},
author = {Stein SN and Braid LR.},
journal = {Aging cell},
year = {2026},
doi = {10.1111/acel.70780},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging Cell 2026
Open access · CC-BY
Senescent Mesenchymal Stromal Cells Drive Stem Cell Aging Through Dysregulated Chemokine Synthesis
Aging and Disease 2023
Open access · CC-BY
Mesenchymal Stem Cell Senescence during Aging:From Mechanisms to Rejuvenation Strategies
Journal of orthopaedic surgery and research 2026
Citation only
Progress in research on the association between mesenchymal stem cell senescence and knee osteoarthritis.
Cells 2023
Open access · CC-BY
Rejuvenation of Mesenchymal Stem Cells to Ameliorate Skeletal Aging
Biomolecules 2025
Open access · CC-BY
Rejuvenation of Bone Marrow Mesenchymal Stem Cells: Mechanisms and Their Application in Senile Osteoporosis Treatment
Circulation Research 2011
Open access · OA